4133 — Abnova Taiwan Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapSucker Stock

Annual income statement for Abnova Taiwan, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	451	412	382	355	351
Cost of Revenue
Gross Profit	197	201	174	163	156
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	408	347	335	321	337
Operating Profit	43.8	64.4	47.2	34.3	14.2
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	36.3	95	48.5	73.2	-2.03
Provision for Income Taxes
Net Income After Taxes	28.4	74.8	43.7	61.6	-1.14
Net Income Before Extraordinary Items
Net Income	28.4	74.8	43.7	61.6	-1.14
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	28.4	74.8	43.7	61.6	-1.14
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.479	1.23	0.772	1.02	0.011
Dividends per Share